Document is current
Any future updates will be listed below
-
Authors
Raschi, Emanuel https://orcid.org/0000-0003-0487-7996
Salvo, Francesco
Bate, Andrew
De Ponti, Fabrizio
Poluzzi, Elisabetta
Tuccori, Marco
van Puijenbroek, Eugène
Joshi, Nitin
Khouri, Charles
- License Information
-
More Information
Article History
Accepted: 3 March 2024
First Online: 18 March 2024
Declarations
:
: No funding was received to assist in the preparation of this article.
: Andrew Bate is an employee of GlaxoSmithKline and holds stocks and stock options. Nitin Joshi is the Editor-in-Chief of <i>Drug Safety</i> and a salaried employee of Adis International Ltd/Springer Nature. He declares no relevant conflicts of interest and was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions. Emanuel Raschi, Francesco Salvo, Fabrizio De Ponti, Elisabetta Poluzzi, Marco Tuccori, Eugène van Puijenbroek and Charles Khouri have no conflicts of interest to declare that are directly relevant to the contents of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Emanuel Raschi conceived the Editorial and wrote the first draft. All authors contributed to the design of the Editorial and commented on previous versions. All authors read and approved the final version of this Editorial.
Free to read: This content has been made available to all.
